Skip to main content
. 2020 Dec 5:taaa223. doi: 10.1093/jtm/taaa223

Table 1.

Prevalence estimates for SARS-CoV-2 and serology stratified by participant risk factors (N= 525 supermarket workers)a

Characteristics No. participants SARS-CoV-2 prevalence 95% CI P value Seroprevalenceb 95% CI P value
Overall 525 21.0% (17.7–24.7) 38.1% (34.0–42.3)
Age group (years) 0.709 0.376
20–30 50 22.0% (12.6–35.5) 36.0% (24.0–50.0)
31–40 150 18.0% (12.6–25.0) 32.7% (25.6–40.6)
41–50 171 21.1% (15.6–27.8) 40.9% (33.8–48.5)
>50 154 23.4% (17.3–30.7) 40.9% (33.4–48.9)
Hypertension 0.261 0.648
Yes 69 26.1% (17.1–37.7) 40.6% (29.7–52.5)
No 456 20.2% (16.7–24.1) 37.7% (33.4–42.3)
Diabetes 0.293 0.481
Yes 70 25.7% (16.8–37.2) 34.3% (24.1–46.1)
No 455 20.2% (16.8–24.2) 38.7% (34.3–43.3)
Lung condition 0.581 0.488
Yes 15 26.7% (10.4–53.4) 46.7% (24.0–70.7)
No 552 20.8% (17.5–24.5) 37.8% (33.7–42.1)
Other conditions 0.464 0.093
Yes 9 11.1% (1.5–50.1) 11.1% (1.53–50.1)
No 516 21.1% (17.8–24.9) 38.6% (34.5–42.9)
Smoker 0.040 <0.001
Yes 207 16.4% (12.0–22.1) 28.0% (22.3–34.5)
No 318 24.0% (19.5–29.0) 44.7% (39.3–50.2)

a P values are based on chi-square test of the differences in risk factors and prevalence measures. These P values are not adjusted for the dependence of responses within supermarket locations.

bSeroprevalence defined as either a positive IgM or IgG rapid SARS-CoV-2 antibody test.